Hjem › Tyktarmskræft › Ohio › Cincinnati
Tyktarmskræft kliniske forsøg i Cincinnati, OH
12 studier for Tyktarmskræft søger deltagere på steder i og omkring Cincinnati (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
RekruttererFrivillige med god helbredstilstand velkomne
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- TriHealth Cancer Institute-Westside, Cincinnati
- og 1 flere
Family Communications After Genetic Testing
RekruttererFrivillige med god helbredstilstand velkomne
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- og 4 flere
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
RekruttererFase 3
- University of Cincinnati Medical Center ( Site 2005), Cincinnati
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RekruttererFase 3
- Oncology Hematology Care - Eastgate, Cincinnati
- Oncology Hematology Care Clinical Trials, LLC, Fairfield · 15 mi væk
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
RekruttererFase 3
- University of Cincinnati Cancer Institute, Cincinnati
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Rekrutterer
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- TriHealth Cancer Institute-Westside, Cincinnati
- og 2 flere
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
RekruttererFase 2/3
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- og 4 flere
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
RekruttererFase 1
- Xencor Investigative Site, Cincinnati
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RekruttererFase 1
- The Christ Hospital, Cincinnati
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RekruttererFase 1/2
- Christ Hospital Cancer Center, Cincinnati
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
RekruttererFase 3
- GSK Investigational Site, Cincinnati
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservationsstudie
- Massive Bio SYNERGY-AI site, Cincinnati
Tyktarmskræft forsøg i andre byer
- Boston, MA22 studier
- New York City, NY22 studier
- Houston, TX20 studier
- Nashville, TN16 studier
- Los Angeles, CA16 studier
- Arlington, VA15 studier
- St. Louis, MO15 studier
- Chicago, IL14 studier
- Baldwin Park, CA14 studier
- San Antonio, TX14 studier
- Tampa, FL13 studier
- Baltimore, MD13 studier
Andre studier i Cincinnati
- Ikke-småcellet lungecancer35 studier
- Kræft (alle typer)27 studier
- Brystkræft25 studier
- Hjertesvigt24 studier
- Colorektal kræft21 studier
- Akut myeloid leukæmi20 studier
- Metastatisk cancer20 studier
- Ægstockræft19 studier
- Lungecancer19 studier
- Overvægt19 studier
- Prostatakræft18 studier
- Multipelt myelom17 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.